Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Sale of 7,947 AMLX shares, $256.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 7,947 | $256.0K |
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 16,300 | $1.39M |
| Aug 21, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 22,807 | n/a |
| Jun 22, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 5,925 | n/a |
| Mar 9, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 95,990 | n/a |
| Mar 4, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 6,461 | $94.2K |
| Dec 3, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 6,580 | $94.4K |
| Oct 2, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 12,039 | $175.5K |
| Jun 26, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 7,037 | n/a |
| Jun 23, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 4,000 | n/a |